# Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations

> **NCT02858167** · NA · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 100 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DEVICE:** FDG-PET

## Key facts

- **NCT ID:** NCT02858167
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02858167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02858167, "Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02858167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*